Asset Details
Do you wish to reserve the book?
Update on Routine Immunizations for Children and Adolescents
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Update on Routine Immunizations for Children and Adolescents
Do you wish to request the book?
Update on Routine Immunizations for Children and Adolescents
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Update on Routine Immunizations for Children and Adolescents
2025
Overview
Childhood and adolescent immunizations compose a valuable public health tool to prevent infection, morbidity, and mortality. The American Academy of Family Physicians recommends that patients receive all recommended immunizations from their usual source of primary care and does not support nonmedical immunization exemptions. Maintaining high vaccination coverage is crucial for preventing outbreaks of vaccine-preventable diseases. Less than 70% of US children have received the full series of recommended vaccinations at 24 months of age. Using electronic health record reminders and creating standing orders to vaccinate according to protocol at every visit can address practice barriers to vaccination. Whereas most routine childhood immunizations have remained the same for the past 10 years, several considerable changes have occurred. With few exceptions, COVID-19 immunizations are recommended annually for all children to prevent disease and hospitalization and to decrease the risk of post–COVID-19 condition. New pneumococcal vaccine formulations that protect against more serotypes are recommended. Pneumococcal vaccination decreases the risk of meningitis, pneumonia, and possibly acute otitis media in children. Either respiratory syncytial virus immunization for the mother between 32 and 36 weeks of gestation from September to January or the monoclonal antibody nirsevimab for the infant from October to March are now recommended for all mother-infant dyads to prevent severe illness.
Publisher
American Academy of Family Physicians
Subject
Academies and Institutes - standards
/ Antibodies, Monoclonal, Humanized
/ Babies
/ Child
/ COVID-19 - prevention & control
/ Family Medicine/General Medicine
/ Female
/ Humans
/ Male
/ Mass Vaccination - standards
/ Patients
/ Physicians, Family - standards
/ Pneumococcal Infections - prevention & control
/ Post-Acute COVID-19 Syndrome - prevention & control
/ Respiratory Syncytial Virus Infections - prevention & control
/ Tetanus
